Docetaxel plus Androgen Deprivation Therapy as First-Line Treatment in High Volume Metastatic Hormone-Sensitive Prostate Cancer
Keywords: Cairo University, Faculty of Medicine, Egypt
BACKGROUND: The addition of docetaxel to androgen deprivation therapy (ADT) as a first-line treatment has shown significant improvement in overall survival for patients with high volume metastatic hormone-sensitive prostate cancer (mHSPC). The CHAARTED and STAMPEDE trials have demonstrated the effic...